Engineering approaches for studying immune-tumor cell interactions and immunotherapy

Summary: This review describes recent research that has advanced our understanding of the role of immune cells in the tumor microenvironment (TME) using advanced 3D in vitro models and engineering approaches. The TME can hinder effective eradication of tumor cells by the immune system, but immunothe...

Full description

Bibliographic Details
Main Authors: Sarah E. Shelton, Huu Tuan Nguyen, David A. Barbie, Roger D. Kamm
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004220311822
id doaj-71c58e95598b4a84a7ea49bab20885c7
record_format Article
spelling doaj-71c58e95598b4a84a7ea49bab20885c72021-01-24T04:28:59ZengElsevieriScience2589-00422021-01-01241101985Engineering approaches for studying immune-tumor cell interactions and immunotherapySarah E. Shelton0Huu Tuan Nguyen1David A. Barbie2Roger D. Kamm3Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USADepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USADepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USADepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Corresponding authorSummary: This review describes recent research that has advanced our understanding of the role of immune cells in the tumor microenvironment (TME) using advanced 3D in vitro models and engineering approaches. The TME can hinder effective eradication of tumor cells by the immune system, but immunotherapy has been able to reverse this effect in some cases. However, patient-to-patient variability in response suggests that we require deeper understanding of the mechanistic interactions between immune and tumor cells to improve response and develop novel therapeutics. Reconstruction of the TME using engineered 3D models allows high-resolution observation of cell interactions while allowing control of conditions such as hypoxia, matrix stiffness, and flow. Moreover, patient-derived organotypic models are an emerging tool for prediction of drug efficacy. This review highlights the importance of modeling and understanding the immune TME and describes new tools for identifying new biological targets, drug testing, and strategies for personalized medicine.http://www.sciencedirect.com/science/article/pii/S2589004220311822Components of the Immune SystemCancerBioengineering
collection DOAJ
language English
format Article
sources DOAJ
author Sarah E. Shelton
Huu Tuan Nguyen
David A. Barbie
Roger D. Kamm
spellingShingle Sarah E. Shelton
Huu Tuan Nguyen
David A. Barbie
Roger D. Kamm
Engineering approaches for studying immune-tumor cell interactions and immunotherapy
iScience
Components of the Immune System
Cancer
Bioengineering
author_facet Sarah E. Shelton
Huu Tuan Nguyen
David A. Barbie
Roger D. Kamm
author_sort Sarah E. Shelton
title Engineering approaches for studying immune-tumor cell interactions and immunotherapy
title_short Engineering approaches for studying immune-tumor cell interactions and immunotherapy
title_full Engineering approaches for studying immune-tumor cell interactions and immunotherapy
title_fullStr Engineering approaches for studying immune-tumor cell interactions and immunotherapy
title_full_unstemmed Engineering approaches for studying immune-tumor cell interactions and immunotherapy
title_sort engineering approaches for studying immune-tumor cell interactions and immunotherapy
publisher Elsevier
series iScience
issn 2589-0042
publishDate 2021-01-01
description Summary: This review describes recent research that has advanced our understanding of the role of immune cells in the tumor microenvironment (TME) using advanced 3D in vitro models and engineering approaches. The TME can hinder effective eradication of tumor cells by the immune system, but immunotherapy has been able to reverse this effect in some cases. However, patient-to-patient variability in response suggests that we require deeper understanding of the mechanistic interactions between immune and tumor cells to improve response and develop novel therapeutics. Reconstruction of the TME using engineered 3D models allows high-resolution observation of cell interactions while allowing control of conditions such as hypoxia, matrix stiffness, and flow. Moreover, patient-derived organotypic models are an emerging tool for prediction of drug efficacy. This review highlights the importance of modeling and understanding the immune TME and describes new tools for identifying new biological targets, drug testing, and strategies for personalized medicine.
topic Components of the Immune System
Cancer
Bioengineering
url http://www.sciencedirect.com/science/article/pii/S2589004220311822
work_keys_str_mv AT saraheshelton engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy
AT huutuannguyen engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy
AT davidabarbie engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy
AT rogerdkamm engineeringapproachesforstudyingimmunetumorcellinteractionsandimmunotherapy
_version_ 1724326694385352704